Table 33, BCVA: categorical change at 2 years (10-category; RE; meta-regression) – input data - Age-related macular degeneration - NCBI Bookshelf

Warning: The NCBI web site requires JavaScript to function. more...

Table 33BCVA: categorical change at 2 years (10-category; RE; meta-regression) – input data

	Change in ETDRS letters		Aflib\|0.5\|Loading-->PRN	Aflib\|2\| Loading-->PRN	Beva\|1.25\|1mo	Beva\|1.25\|Loading --> PRN <6wkly	Beva\|1.25\|PRN <6wkly	PDT\|\|PRN >6wkly	Rani\|0.5\|1mo	Rani\|0.5\|Loading --> PRN <6wkly	Rani\|0.5\|PRN <6wkly	Rani\|2\|1mo	Rani\|2\|Loading --> PRN <6wkly	Sham\|\|
	Minimum	Minimum	Aflib\|0.5\|Loading-->PRN	Aflib\|2\| Loading-->PRN	Beva\|1.25\|1mo	Beva\|1.25\|Loading --> PRN <6wkly	Beva\|1.25\|PRN <6wkly	PDT\|\|PRN >6wkly	Rani\|0.5\|1mo	Rani\|0.5\|Loading --> PRN <6wkly	Rani\|0.5\|PRN <6wkly	Rani\|2\|1mo	Rani\|2\|Loading --> PRN <6wkly	Sham\|\|
ANCHOR 2006		−30						23	2
	−29	−15						26	29
	−14	−1						53	32
	0	+14						32	112
	+15	+29						6	73
	+30							3	32
CATT 2011		−15			10		29		9		19
	−14	+14			78		151		81		164
	+15				41		71		44		81
HARBOR		−15							16	25		27	23
	−14	+14							164	159		144	155
	+15								95	91		103	95
IVAN 2013		−30			4	0			4	4
	−29	−15			8	11			4	11
	−14	−5			19	11			12	19
	−4	+4			35	36			33	32
	+5	+14			36	48			39	47
	+15	+29			19	15			32	18
	+30				5	2			9	4
MARINA		−15							43					112
	−14	+14							293					117
	+15								142					9
TAP 1999		−30						73						62
	−29	−15						116						67
	−14	−5						92						31
	−4	+4						59						26
	+5	+14						26						13
	+15	+29						33						8
	+30							3						0
VIEW 1&2 POOLED		−30	▬^a	▬^b						▬^b
	−29	−15	▬^b	▬^b						▬^b
	−14	−10	▬^b	▬^b						▬^b
	−9	−5	▬^b	▬^b						▬^b
	−4	−1	▬^b	▬^b						▬^b
	0	+4	▬^b	▬^b						▬^b
	+5	+9	▬^b	▬^b						▬^b
	+10	+14	▬^b	▬^b						▬^b
	+15	+29	▬^b	▬^b						▬^b
	+30		▬^b	▬^b						▬^b
VIM 2005		−30						4						13
	−29	−15						13						10
	−14	−5						4						5
	−4	+4						4						5
	+5	+14						4						3
	+15							3						1
VIO		−30						56						30
	−29	−15						59						34
	−14	−5						43						30
	−4	+4						48						19
	+5							38						7
VIP 2001 Occ only		−30						48						43
	−29	−15						43						20
	−14	−5						29						10
	−4	+4						25						14
	+5	+14						13						4
	+15	+29						8						1
VIP 2001 PC or MC		−30						19						11
	−29	−15						11						2
	−14							29						9

: Where individual trials have more than 1 arm representing a treatment option, they have been pooled in this table for ease of interpretation, although they are entered as separate datapoints in the NMA.

From: Appendix G, Network meta-analysis

Cover of Age-related macular degeneration

Age-related macular degeneration: diagnosis and management.

NICE Guideline, No. 82.

London: National Institute for Health and Care Excellence (NICE); 2018 Jan.

Copyright © NICE 2018.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.